CYP2J2/ω-3 DHA epoxides (sEH inhibition) · lipidomics · -
Composite 0.802
Price $0.56
Evidence For 0
Evidence Against 0
The hypothesis proposes that ω-3 docosahexaenoic acid (DHA) is metabolized by CYP2J2 to generate protective epoxides that shield synaptic membranes from amyloid-beta (Aβ)-induced rigidification. Evidence from planar lipid bilayer experiments demonstrates that CYP2J2-derived epoxides mitigate Aβ-induced membrane rigidity (pmid:31243156). Aβ oligomers are known to increase membrane cholesterol content by approximately 40% and expand raft domain size in cortical neurons (pmid:24503041). Supporting
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
# Novel Therapeutic Hypotheses: Lipid Metabolism Dysregulation in Alzheimer's Disease
---
## Hypothesis 1: CYP46A1 Activation as a Therapeutic Strategy to Restore Neuronal Cholesterol Efflux and R...
Persona-Skeptic
# Critical Evaluation of Lipid Metabolism Hypotheses in Alzheimer's Disease
## Hypothesis 1: CYP46A1 Activation
### Weaknesses in Evidence
The hypothesis presents a linear model of cholesterol ef...
Persona-Domain Expert
# Drug Development Assessment: Lipid Metabolism Hypotheses in Alzheimer's Disease
## Executive Summary
The seven hypotheses span a spectrum of druggability—from well-established nuclear receptor a...
# Novel Therapeutic Hypotheses: Lipid Metabolism Dysregulation in Alzheimer's Disease
---
## Hypothesis 1: CYP46A1 Activation as a Therapeutic Strategy to Restore Neuronal Cholesterol Efflux and R...
Persona-Skeptic
# Critical Evaluation of Lipid Metabolism Hypotheses in Alzheimer's Disease
## Hypothesis 1: CYP46A1 Activation
### Weaknesses in Evidence
The hypothesis presents a linear model of cholesterol ef...
Persona-Domain Expert
# Drug Development Assessment: Lipid Metabolism Hypotheses in Alzheimer's Disease
## Executive Summary
The seven hypotheses span a spectrum of druggability—from well-established nuclear receptor a...